Chapter 44
description
Transcript of Chapter 44
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Chapter 44
Drugs Acting on the Renin-Angiotensin-Aldosterone System
2Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Drugs Acting on the Renin-Angiotensin-Aldosterone System
Physiology of the renin-angiotensin-aldosterone system
Angiotensin-converting enzyme inhibitors Angiotensin II receptor blockers Aldosterone antagonists
3Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Physiology of the Renin-Angiotensin-Aldosterone System
Type of angiotensin Angiotensin I Angiotensin II Angiotensin III
Actions of angiotensin II Vasoconstriction Release of aldosterone Alteration of cardiac and vascular structure
4Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Physiology of the Renin-Angiotensin-Aldosterone System
Actions of aldosterone Regulation of blood volume and blood pressure Pathologic cardiovascular effects
5Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Fig. 44–1. Regulation of blood pressure by the renin-angiotensin-aldosterone system.
6Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Physiology of the Renin-Angiotensin-Aldosterone System
Formation of angiotensin II by renin and angiotensin-converting enzyme (ACE) Renin
• Catalyzes the formation of angiotensin I from angiotensinogen
• Regulation of renin release Angiotensin-converting enzyme (kinase II)
• Catalyzes the conversion of angiotensin I (inactive) to angiotensin II (highly active)
7Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Physiology of the Renin-Angiotensin-Aldosterone System
Regulation of blood pressure by the renin-angiotensin-aldosterone system Helps regulate blood pressure in the presence of
hemorrhage, dehydration, or sodium depletion Acts in two ways
• Constricts renal blood vessels• Acts on the kidney to promote retention of sodium and
water and excretion of potassium Tissue (local) angiotensin II production
8Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Angiotensin-Converting Enzyme Inhibitors
Mechanism of action and overview of pharmacologic effects Reducing levels of angiotensin II Increasing levels of bradykinin
Pharmacokinetics
9Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Angiotensin-Converting Enzyme Inhibitors
Therapeutic uses Hypertension Heart failure Myocardial infarction (MI) Diabetic and nondiabetic nephropathy Prevention of MI, stroke, and death in patients at
high cardiovascular risk
MI = myocardial infarction.
10Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Fig. 44–2. Overview of ACE inhibitor actions and pharmacologic effects.
11Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Angiotensin-Converting Enzyme Inhibitors
Adverse effects First-dose hypotension Fetal injury Cough Angioedema Hyperkalemia Dysgeusia and rash Renal failure Neutropenia
12Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Angiotensin-Converting Enzyme Inhibitors
Drug interactions Diuretics Antihypertensive agents Drugs that raise potassium levels Lithium Nonsteroidal anti-inflammatory drugs
13Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Angiotensin-Converting Enzyme Inhibitors
Preparations, dosage, and administration Except for enalaprilat, all ACE inhibitors are
administered orally All available in single-drug formulations Except for captopril and moexipril, all oral
formulations may be administered without regard to meals
14Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Angiotensin II Receptor Blockers Mechanism of action and overview of
pharmacologic effects Block access of angiotensin II Cause dilation of arterioles and veins Prevent angiotensin II from inducing pathologic
changes in cardiac structure Reduce excretion of potassium Decrease release of aldosterone Increase renal excretion of sodium and water Do not inhibit kinase II Do not increase levels of bradykinin
15Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Fig. 44–3. Elevation of glomerular filtration pressure by angiotensin II.
16Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Angiotensin II Receptor Blockers
Therapeutic uses Hypertension, heart failure, myocardial infarction Diabetic nephropathy If unable to tolerate ACE inhibitors: protection
against MI, stroke, and death from cardiovascular (CV) causes in high-risk patients
Migraine headache May prevent development of diabetic retinopathy New data show that ACE inhibitors and
angiotensin II receptor blockers (ARBs) are not effective for primary prevention of nephropathy in normotensive diabetic patients
17Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Angiotensin II Receptor Blockers Adverse effects
Angioedema Fetal harm Renal failure Possibility of promoting cancer
18Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Direct Renin Inhibitors Aliskiren (Tekturna)
Binds tightly with renin and inhibits the cleavage of angiotensinogen to angiotensin I
Side effects• Angioedema, cough, GI effects, hyperkalemia,
fetal injury, and death
19Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Aldosterone Antagonists Eplerenone (Inspra)
Mechanism of action• Selective blockade of aldosterone receptors
Therapeutic uses• Hypertension• Heart failure
Pharmacokinetics• Absorption is not affected by food
Adverse effects• Hyperkalemia
20Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Aldosterone Antagonists Eplerenone (Inspra) (cont’d)
Drug interactions• Inhibitors of CYP3A4• Drugs that raise potassium levels• Use with caution when combined with lithium
21Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Aldosterone Antagonists Spironolactone (Aldactone)
Mechanism of action• Blocks aldosterone receptors• Binds with receptors for other steroid hormones
Therapeutic uses• Hypertension• Heart failure
22Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Aldosterone Antagonists Spironolactone (Aldactone) (cont’d)
Adverse effects• Hyperkalemia• Gynecomastia• Menstrual irregularities• Impotence• Hirsutism• Deepening of the voice